THOMSON MEDICAL GROUP LIMITED
(SGX: A50)

The Company was incorporated in Singapore on 31 December 1999 under the name of aspnetcentre Ltd, an IT services and solutions provider. As of 16 October 2003, the company changed its name to Rowsley Ltd. and has ceased all businesses with operational losses under the Group. Today, the Company's core business is in investments, investment holding & strategic investments and other related activities. Rowsley’s strategy and direction are designed to provide a focused portfolio, which it plans to strengthen with significant investments in the coming years. Geographically, the Company is exploring growth markets around Asia and beyond. With a strong focus and clear vision, Rowsley envisions to be successful in terms of growth, performance and value for all shareholders. Following the completion of acquisition of Thomson Medical Pte Ltd and Bursa-listed TMC Life Sciences Berhad, the Group become a leading healthcare player in Southeast Asia and changed its company name from “Rowsley Ltd” to “Thomson Medical Group Limited”. Trading under new name with effect from 30 Apr 2018.

0.048 -

+0.001 (+2.13%)
Range 0.047 - 0.048   (2.13%)
Open 0.047
Previous Close 0.047
Bid Price 0.047
Bid Volume ('000) 1,842.8
Ask Price 0.048
Ask Volume ('000) 1,593.9
Volume ('000) 62
Value 2,925
Remark -
Delayed prices. Updated at 21 Nov 2024 17:05.
Data powered by
View All Events

About Thomson Medical

The Company was incorporated in Singapore on 31 December 1999 under the name of aspnetcentre Ltd, an IT services and solutions provider. As of 16 October 2003, the company changed its name to Rowsley Ltd. and has ceased all businesses with operational losses under the Group. Today, the Company's core business is in investments, investment holding & strategic investments and other related activities. Rowsley’s strategy and direction are designed to provide a focused portfolio, which it plans to strengthen with significant investments in the coming years. Geographically, the Company is exploring growth markets around Asia and beyond. With a strong focus and clear vision, Rowsley envisions to be successful in terms of growth, performance and value for all shareholders. Following the completion of acquisition of Thomson Medical Pte Ltd and Bursa-listed TMC Life Sciences Berhad, the Group become a leading healthcare player in Southeast Asia and changed its company name from “Rowsley Ltd” to “Thomson Medical Group Limited”. Trading under new name with effect from 30 Apr 2018.

Loading Chart...

Please login to view stock data and analysis